
Medical Innovation Xchange Welcomes LND Therapeutics as Our Newest Affiliate Company
Medical Innovation Xchange (MIX) is thrilled to welcome LND Therapueutics as our newest affiliate company in our expanding community of Canadian medtech innovators. At LND Therapeutics, they are harnessing the power of the microbiome to help more cancer patients benefit from immunotherapy through LND101, an oral microbiome therapeutic designed to modify the gut microbiome and enhance immunotherapy.











